United States Antimony files prospectus supplement

United States Antimony Corporation (NYSE American:UAMY), a company specializing in the smelting and refining of nonferrous metals with a market capitalization of $388 million and impressive 411% return over the past six months, has filed a prospectus supplement with the Securities and Exchange Commission (SEC). According to InvestingPro data, the company maintains strong liquidity with a current ratio of 5.16. This filing, which took place on Monday, April 25, 2025, pertains to a Sales Agreement with A.G.P./Alliance Global Partners (NYSE:GLP) dated November 12, 2024, under the company’s existing Registration Statement on Form S-3 (No. 333-284057).

The prospectus supplement registers shares of the company’s common stock, each with a par value of $0.01, that may be issued and sold pursuant to the Sales Agreement. United States Antimony, based in Dallas, Texas, has also included an opinion and consent from the law firm Hall Booth Smith, P.C., confirming the validity of the common stock that may be sold under this agreement. The company has demonstrated strong revenue growth of 72% in the last twelve months, with InvestingPro analysis revealing 13 additional key insights available to subscribers.

The filing of this prospectus supplement allows United States Antimony to offer and sell its shares through A.G.P./Alliance Global Partners, although it does not constitute an offer to sell or a solicitation of an offer to buy any securities. The sale of these securities will be subject to compliance with applicable state and jurisdictional securities laws and regulations.

Investors and interested parties should note that the information presented in this article is based on the company’s SEC filing and does not represent an offer of securities or a prediction of the company’s financial future. However, analysts forecast positive earnings of $0.18 per share for fiscal year 2025, suggesting potential growth ahead. The filing ensures that United States Antimony Corporation maintains compliance with the SEC’s regulations and provides transparency to its current and potential investors regarding the availability of its common stock for sale. For comprehensive analysis and detailed insights, investors can access the full Pro Research Report available on InvestingPro.

In other recent news, United States Antimony Corporation reported a remarkable performance in Q4 2024, achieving record revenues of $14.9 million, which represents a 72% increase compared to the previous year. The company turned a gross profit of $3.5 million, a significant improvement from a loss of $3.3 million in the prior year. Additionally, U.S. Antimony has restarted operations at its Madero Smelter Plant in Coahuila, Mexico, aiming for a production output of approximately 200 tons per month by the end of 2025. The company has also received a Buy rating from B. Riley, with a price target of $3.00, highlighting its strategic importance in the U.S. market amid China’s export restrictions on antimony. The Thompson Falls smelter in Montana is noted for its annual ore capacity of approximately 3,840 tons, with plans to more than double this capacity. Recent shipments of antimony ore have arrived at Mexican ports, with processing already underway, indicating a ramp-up in production. U.S. Antimony’s strategic initiatives, including expansions and acquisitions, are well-aligned with the favorable pricing environment for antimony metal. These developments underscore the company’s growth potential and strategic positioning in the critical minerals sector.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.